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TRENDS IN CAUSE OF DEATH AMONG PUERTO RICAN AND UNITED STATES MULTIPLE 
MYELOMA PATIENTS 
 
Castañeda-Avila MA, MS1; Ortiz-Ortiz KJ, DrPH2; Torres-Cintrón CR, MPH2; Epstein MM, ScD3 
1Graduate School of Biomedical Sciences, University of Massachusetts Medical School; 2Puerto 
Rico Central Cancer Registry, University of Puerto Rico Comprehensive Cancer Center; 
3Meyers Primary Care Institute and the Department of Medicine, University of Massachusetts 
Medical School 
 
Background/Objective: Multiple myeloma (MM) is an incurable, yet treatable, cancer of 
plasma cells. Due to recent improvements in treatment, people diagnosed with MM have been 
living longer, and other co-morbid conditions may be of increasing importance. This study 
examines temporal trends in specific causes of death among MM patients in Puerto Rico (PR) 
and United States (US).  
 
Methods: We analyzed primary cause of death among all incident MM cancer cases recorded 
in the Puerto Rico Central Cancer Registry (PRCCR) (n=3,018) and the US Surveillance, 
Epidemiology, and End Results Program (SEER) (n=67,733) between 1987-2013, overall and 
by follow-up time, age, and sex. We calculated the cumulative incidence of death due to seven 
selected causes and analyzed age-adjusted mortality trends by MM and other causes using 
joinpoint regression.  
 
Results: MM accounted for 71.7% and 71.3% of all reported deaths in PR and US, respectively, 
among people diagnosed with MM. In PR, the proportion of patients that died from MM 
decreased with increasing follow-up time since diagnosis (72.3% of deaths with ≤2 years vs 
65.6% with >5 years of follow-up) and the proportion of patients who died from circulatory (4.6% 
vs 9.0%) and respiratory system (3.7% vs 5.0%) diseases increased slightly. A similar trend of 
decreasing MM deaths with follow-up time was observed in the US (73.2% of deaths with ≤2 
years vs 66.5% with >5 years of follow-up). Joinpoint regression showed a decreasing trend in 
MM mortality in the US (APC1987-2007=-2.8%, and APC2007-2013=-18.4%) and a similar, though 
somewhat weaker, trend in PR (APC1987-2013=-2.73). 
 
Conclusion: In both PR and the US, people diagnosed with MM are still more likely to die from 
MM than from another cause. However, a decrease in MM mortality is evident, particularly in 
more recent years, but this decrease is lower in Puerto Rico.  
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